2018
DOI: 10.1016/j.tube.2018.02.009
|View full text |Cite
|
Sign up to set email alerts
|

Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

4
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 64 publications
4
11
0
Order By: Relevance
“…By sequencing the kat G gene, mutations in 106 of our isolates (80.9%) at 315 codons were observed, agreeing also with other studies from the same state [ 22 ] and other regions [ 4 ]. Regarding the inh A gene, 41 MDR M.tb isolates (31.3%) had mutation in the promoter region of the gene.…”
Section: Discussionsupporting
confidence: 92%
See 3 more Smart Citations
“…By sequencing the kat G gene, mutations in 106 of our isolates (80.9%) at 315 codons were observed, agreeing also with other studies from the same state [ 22 ] and other regions [ 4 ]. Regarding the inh A gene, 41 MDR M.tb isolates (31.3%) had mutation in the promoter region of the gene.…”
Section: Discussionsupporting
confidence: 92%
“…In the analysis of the rpo B gene, the most frequent mutations found were in the 531, 516 and 526 codons, the same as reported in other studies with RIF-resistant isolates [ 22 , 28 ]. The mutation in the codon 531 stands out with higher frequency (61.8%), also found in other studies in the same state [ 22 , 29 ], in other regions of Brazil [ 30 , 31 ] and other countries [ 28 ]. The codon 516 in the rpo B gene was mutated in 16.8% of the isolates and 2.3% of them had single nucleotide exchange, other studies show a bigger mutation rate with SNP in this codon [ 30 , 32 ].…”
Section: Discussionsupporting
confidence: 78%
See 2 more Smart Citations
“…Furthermore, the treatment outcome is most likely unfavorable and failure to identify an INH-resistant isolate is equivalent to losing the efficacy of one of the drugs and compromising the basic regimen of treatment. (17) The lack of adequate treatment to combat an INH resistant isolate could also be inducing gene-level changes (mutations), generating MDR clones, since resistance to RIF comes in sequence. (2) The qPCR assays performed in this study identified the most known mutations in genetic regions associated with INH resistance (katG 315 G/C and inhA -15 C/T; GenBank: (MG995339, MG995338, MG995265 e CP023597 -National Centre for Biotechnology Information -NCBIhttps: //www.ncbi.…”
Section: Discussionmentioning
confidence: 99%